Newpath Partners News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Metsera Launches With $290M in Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Softbank vision fundF prime capitalMubadala capitalNewpath partners

Weight-loss drug developer Metsera raises $290 million in funding

Weight-loss drug developer Metsera raises $290 million in funding
devdiscourse.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from devdiscourse.com Daily Mail and Mail on Sunday newspapers.

Clive meanwellEli lillyIan readPopulation health partnersMedicines companyPopulation healthSoftbank vision fundNovo nordiskMubadala capitalExecutive officer clive meanwellF prime capitalNewpath partners

Arch-backed obesity biotech launches with $290M

Arch-backed obesity biotech launches with $290M
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomWhit bernardSteven marsoClive meanwellBrian hubbardChristopher coxJohn amatrudaNovo nordiskImperial college londonPopulation health partnersMedicines companySoftbank vision fundEli lillyClinical stage metseraFierce biotech

Cloaking Device: Liu, Joung Launch $100M Nvelop Therapeutics to Advance Delivery of Genetic Cargo

Cloaking Device: Liu, Joung Launch $100M Nvelop Therapeutics to Advance Delivery of Genetic Cargo
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

United statesJeff walshJeff marrazzoFeng zhangRobertb colvinMelissa bonnerKevin bittermanDavidr liuJennifer doudnaJ keith joungDeborah palestrantThomas cahillAlisa mcgrathJess alstonBroad instituteHoward hughes medical institute

Nvelop and Seaport Raise $100M in Rounds, Tap Bluebird and Karuna Execs

A pair of biotechs burst onto the scene Tuesday, exiting stealth with $100 million in financing each and tapping executives who made their names at bluebird bio and Karuna Therapeutics.

United statesDavid liuKeith joungSteven paulEli lillyMelissa bonnerJeff walshDaphne zoharPuretech healthAtlas ventureBristol myers squibbBroad instituteNicole beanNvelop therapeuticsSeaport therapeuticsKaruna therapeutics